Market Access
Find out everything you need to know about the latest pricing, reimbursement and market access strategies that will drive your business development.
Pharma companies are over-estimating cyber security
July 31 by Pharmaceuticals & Biotechnology EditorA Pharma IQ survey reveals over-confidence across the pharma industry when it comes to cyber security and data security.
Will ocean freight be the dominant mode of transport for pharmaceutical payloads?
July 10 by Pharmaceuticals & Biotechnology EditorCurrently, around 20% of pharmaceutical payloads are moved via ocean freight however it’s forecast this will increase to approximately 75% within the next 10 years
Russia’s Pharmaceutical market 2018
June 11 by Adam MusprattIs the Russian pharmaceutical market on course for rapid growth or will it devolve into a market plagued by staleness and drug shortages?
Cold Chain Global Forum Online - 26th June 2018
May 31 by Pharma IQExclusive case studies from global pharmaceutical organisations, obtain awareness of the latest market trends, Get insights into the latest services and solutions in pharma logistics, Learn how to neg...
Temperature Controlled Logistics Live 2018 - 13th March 2018
May 30 by Pharma IQAn online series featuring live interactive webinars, on-demand webinars, whitepapers, infographics, commentary articles and interviews all focusing on supply chain excellence with temperature sensiti...
Thrombolysis is still the best treatment for acute stroke
May 17 by George Clinical RepresentativeRecent research has determined that thrombolysis is still the best treatment for acute stroke patients.
Doctors and the influence of the digital boom
May 11 by Scott FreemanDoctors are people too, seeking engagement and enjoyment in their day-to-day lives. And pharmaceutical companies are taking notice.
Malaria: Scientists urged to not underestimate CRISPR’s dangers
April 23 by Chanice HenrySimilar to new Hollywood feature Rampage, a recent study has urged the life sciences industry not to underestimate the dangers that could hide within CRISPR Cas9.
MHRA grants UK patients early access to treatment for painful genetic disorder
March 26 by Chanice HenryA treatment for a debilitating genetic lipid disorder has been awarded a place on the Early Access to Medicines Scheme by the MHRA.
Physicians urged to talk money to end financial nightmares for cancer patients
March 05 by Pharma IQ NewsAs groundbreaking therapies hand patients new hopes, a whitepaper has urged the industry to treat and prevent the financial burdens that plague cancer patients
Temperature Controlled Logistics Live 2018
February 23 by Pharma IQAn online series featuring live interactive webinars, on-demand webinars, whitepapers, infographics, commentary articles and interviews all focusing on supply chain excellence with temperature sensiti...
World map: Risk forecast for 2018
February 13 by Pharma IQ NewsPharma businesses operating on an international scale will have to negotiate fragile climates in 2018